WORCESTER, Mass., Aug. 27, 2009 (GLOBE NEWSWIRE) -- The synthetic vaccine platform technology of Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) was featured last week at the first International Swine Flu Conference in Washington, DC.
